InterventionsHuman trial
NA-931, a Novel Quadruple IGF-1-1, GLP-1, GIP, and Glucagon Receptor Agonist Reduces Body Weight without Muscle Loss
ADA Scientific Sessions 2025 Abstract
The paper
TRAN LL
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Oral 143-OR